NeuroPace, Inc.
NASDAQ:NPCE
10.97 (USD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 79.906 | 65.421 | 45.52 | 45.183 | 41.138 | 36.972 |
| Cost of Revenue
| 20.821 | 17.299 | 13.027 | 11.748 | 10.866 | 10.508 |
| Gross Profit
| 59.085 | 48.122 | 32.493 | 33.435 | 30.272 | 26.464 |
| Gross Profit Ratio
| 0.739 | 0.736 | 0.714 | 0.74 | 0.736 | 0.716 |
| Reseach & Development Expenses
| 23.653 | 20.778 | 21.946 | 18.211 | 15.695 | 18.294 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 57.103 | 54.518 | 51.341 | 38.961 | 27.628 | 30.201 |
| Other Expenses
| 0 | 0 | -0.337 | -5.381 | 0.218 | 1.282 |
| Operating Expenses
| 80.756 | 75.296 | 73.287 | 57.172 | 43.323 | 48.495 |
| Operating Income
| -21.671 | -27.174 | -40.794 | -23.737 | -13.051 | -22.031 |
| Operating Income Ratio
| -0.271 | -0.415 | -0.896 | -0.525 | -0.317 | -0.596 |
| Total Other Income Expenses Net
| -5.47 | -5.782 | -6.288 | -12.343 | -11.227 | -7.942 |
| Income Before Tax
| -27.141 | -32.956 | -47.082 | -36.08 | -24.278 | -29.973 |
| Income Before Tax Ratio
| -0.34 | -0.504 | -1.034 | -0.799 | -0.59 | -0.811 |
| Income Tax Expense
| 0 | 0 | 6.288 | 2.029 | 11.704 | 10.767 |
| Net Income
| -27.141 | -32.956 | -53.37 | -38.109 | -35.982 | -40.74 |
| Net Income Ratio
| -0.34 | -0.504 | -1.172 | -0.843 | -0.875 | -1.102 |
| EPS
| -0.93 | -1.27 | -2.17 | -1.56 | -1.51 | -1.71 |
| EPS Diluted
| -0.93 | -1.27 | -2.17 | -1.56 | -1.51 | -1.71 |
| EBITDA
| -16.574 | -22.834 | -36.566 | -28.374 | -12.48 | -20.067 |
| EBITDA Ratio
| -0.207 | -0.349 | -0.869 | -0.628 | -0.303 | -0.543 |